Tag: DAA therapy
-
DAA Therapy: Persistent HCC Risk in HIV-HCV Coinfection Explained
Understanding the Context: HIV, HCV, and HCC Hepatitis C virus (HCV) infection and human immunodeficiency virus (HIV) coinfection pose unique health challenges. In the past decade, direct-acting antivirals (DAAs) transformed HCV treatment, offering high cure rates and improved liver outcomes. However, even after what appears to be a sustained virologic response or cure, researchers have…
-
DAA Therapy and HCC Risk in HIV-HCV Coinfection: Decline Over Time
Overview: HIV, HCV, and the risk of hepatocellular carcinoma Hepatocellular carcinoma (HCC) remains a major concern for people living with HIV who have a history of hepatitis C virus (HCV) infection. Even after successful HCV cure with direct-acting antivirals (DAAs), researchers have observed that the risk of developing HCC does not disappear entirely. This evolving…